Login to Your Account

CytRx Raises $8.7M, Forms Subsidiary For RNAi Efforts

By Randall Osborne

Thursday, September 18, 2003
Raising $8.7 million in a private placement, CytRx Corp. said it's using most of the money to form a subsidiary that will develop orally active small-molecule RNA interference drugs for obesity and Type II diabetes. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription